A Study of JNJ-64407564 in Japanese Participants With Relapsed or Refractory Multiple Myeloma

NCT04773522 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Janssen Pharmaceutical K.K.